Viewing Study NCT05037669


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2025-12-25 @ 8:48 PM
Study NCT ID: NCT05037669
Status: WITHDRAWN
Last Update Posted: 2023-06-22
First Post: 2021-08-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma
Sponsor: University of Pennsylvania
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module